Has Kevin Ma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,814 in general payments to Kevin Ma, MD across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kevin Ma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kevin Ma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kevin Ma, MD

Critical Care Medicine · Philadelphia, PANPI 1013216357

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (35.9%), education and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Pulmonx Corporation at 47.1% of the total. Among critical care medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,814in general payments, 2019–2025

Across 61 payments — averaging $242.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pulmonx Corporation$7K
Intuitive Surgical$7K
Merit Medical Systems Inc$355
Verona Pharma, Inc.$290
Johnson & Johnson$251
Siemens Medical Solutions USA, Inc.$196
plus $147 from 4 others

$179,285in research payments, 2019–2025

Across 27 payments — averaging $6640.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pulmonx Corporation$106K
Sanofi US Services Inc.$71K
Optellum Ltd$2K

What the payments were for

Consulting fees$5,31336%
Speaking & faculty fees$1,0007%
Travel & lodging$9236%
Food & beverage$3,36423%
Education$4,21428%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pulmonx Corporation	27	$6,973
Intuitive Surgical	21	$6,601
Merit Medical Systems Inc	2	$355
Verona Pharma, Inc.	2	$290
Johnson & Johnson	4	$251
Siemens Medical Solutions USA, Inc.	1	$196
Medical Device Business Services, Inc.	1	$45
Olympus America Inc.	1	$45
Sanofi	1	$43
Galvanize Therapeutics, Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,814 in reported general payments places this provider in the 90th percentile of 354 critical care medicine providers in Pennsylvania.

See all critical care medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$76,242

Medicare patients

237

Services billed

726

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	25	$18,202
Breztri AerosphereBudesonide/Glycopyr/Formoterol	13	$8,494
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	16	$7,013
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	16	$2,507
Azithromycin	31	$699
Albuterol Sulfate HfaAlbuterol Sulfate	14	$509
Montelukast Sodium	18	$212
Prednisone	16	$28

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Philadelphia

David DibardinoPhiladelphia$63K
Harold PalevskyPhiladelphia$55K
Steven KawutPhiladelphia$34K
Kerri SmithPhiladelphia$30K
Michael BeersPhiladelphia$28K
Daniel DorganPhiladelphia$23K
Belinda Rivera-LebronPhiladelphia$18K
Joshua DiamondPhiladelphia$13K
Gregory TinoPhiladelphia$9K
Anthony LanfrancoPhiladelphia$8K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →